Today, Christine Poole commented about whether IBM-N, XYL-N, JNJ-N, FTS-T, FRII-T, T-T, FFH-T, SLF-T, MFC-T, PM-N, BAC-N, CVX-N, IPL-T, DH-T, AAPL-Q, CAT-N, ENF-T, AGU-T, CAR-Q, TECK.B-T, GILD-Q, CGX-T, HD-N, GOOG-Q, MSFT-Q, CSH.UN-T, MCD-N, UNH-N, AIG-N, UL-N, CPG-T are stocks to buy or sell.
She likes it for the income, growth and the defensive nature of the business. They just bought ITC corp. which is out of the US and expands their presence there. ITC is a regulated electric utility. Over 60% of FTS-T’s earnings are going to be coming from the US now. They have good visibility post- the acquisition to grow their dividend 6% per year until 2021. It has lagged the market, so all in, you should get 12% on this name. (Analysts’ target: $48.55).
They have done well in the pharma side. They just announced the acquisition of a Swiss based pharma company. They grow organically also. They have identified about 10 products they are going to launch in the next three years that have about $1 Billion each. They trade at 16 times earnings and have increased their dividend for 54 consecutive years. (Analysts’ target: $126.32).
They are in the business of transportation, testing and treatment of water. Drinkable water is a very scarce commodity. 21% of revenues are from emerging markets. They are trying to give people access to sanitation. In the US there is a lot of overhaul required on the existing systems. In 2012 state governments cut back because there was no funding. XYL-N also have exposure in the UK. They just acquired a smart metering company and will do some cross selling. (Analysts’ target: $54.00).
(Market Call Minute) You could buy it for exposure to the US economy.